AI Article Synopsis

  • COPD is a chronic lung disease characterized by obstructed airflow, and understanding its molecular mechanisms, particularly DNA methylation's role in gene expression, is crucial.
  • The study identified 81 genes with hypermethylation and low expression, as well as 121 genes with hypomethylation and high expression, highlighting specific genes like CD247 and TREM1 that may help in diagnosing COPD.
  • Additionally, various signaling pathways related to immune response and cell interactions were found to be associated with COPD, suggesting that these genes and pathways could be involved in the disease's progression.

Article Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. DNA methylation can regulate gene expression. Understanding the potential molecular mechanism of COPD is of great importance. The aim of this study was to find differentially methylated/expressed genes in COPD. DNA methylation and gene expression profiles in COPD were downloaded from the dataset, followed by functional analysis of differentially-methylated/expressed genes. The potential diagnostic value of these differentially-methylated/expressed genes was determined by receiver operating characteristic (ROC) analysis. Expression validation of differentially-methylated/expressed genes was performed by experiment and extra online datasets. Totally, 81 hypermethylated-low expression genes and 121 hypomethylated-high expression genes were found in COPD. Among which, 9 core hypermethylated-low expression genes (CD247, CCR7, CD5, IKZF1, SLAMF1, IL2RB, CD3E, CD7 and IL7R) and 8 core hypomethylated-high expression genes (TREM1, AQP9, CD300LF, CLEC12A, NOD2, IRAK3, NLRP3 and LYZ) were identified in the protein-protein interaction (PPI) network. Moreover, these genes had a potential diagnostic utility for COPD. Some signaling pathways were identified in COPD, including T cell receptor signaling pathway, cytokine-cytokine receptor interaction, hematopoietic cell lineage, HTLV-I infection, endocytosis and Jak-STAT signaling pathway. In conclusion, differentially-methylated/expressed genes and involved signaling pathways are likely to be associated with the process of COPD.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15412555.2022.2158324DOI Listing

Publication Analysis

Top Keywords

differentially-methylated/expressed genes
20
expression genes
16
genes
11
chronic obstructive
8
obstructive pulmonary
8
pulmonary disease
8
copd
8
dna methylation
8
gene expression
8
genes copd
8

Similar Publications

Article Synopsis
  • Lung adenocarcinoma (LUAD) is a major cause of cancer deaths, and understanding DNA methylation in early stages could help improve treatment outcomes.
  • Researchers used enzymatic methyl sequencing to analyze 23 tumor samples alongside normal tissues, revealing a more detailed epigenetic landscape than previous methods.
  • The study identified over 30,000 differentially methylated regions and developed a prognostic model based on six significant genes, offering new insights into the role of DNA methylation in early-stage LUAD.
View Article and Find Full Text PDF
Article Synopsis
  • COPD is a chronic lung disease characterized by obstructed airflow, and understanding its molecular mechanisms, particularly DNA methylation's role in gene expression, is crucial.
  • The study identified 81 genes with hypermethylation and low expression, as well as 121 genes with hypomethylation and high expression, highlighting specific genes like CD247 and TREM1 that may help in diagnosing COPD.
  • Additionally, various signaling pathways related to immune response and cell interactions were found to be associated with COPD, suggesting that these genes and pathways could be involved in the disease's progression.
View Article and Find Full Text PDF

Identification of candidate aberrant differentially methylated/expressed genes in asthma.

Allergy Asthma Clin Immunol

December 2022

Department of internal medicine, Qingdao Fuwai Cardiovascular Hospital, 18th Floor north, 201 Nanjing Road, 266034, Qingdao, Shandong, China.

Article Synopsis
  • Asthma, a significant non-communicable disease globally, is linked to changes in gene methylation, prompting an investigation into differentially expressed genes (DEGs) and their pathways using bioinformatics.
  • The study utilized mRNA and gene methylation datasets from the Gene Expression Omnibus (GEO), applying various analysis methods to identify important genes and their interactions related to asthma.
  • Findings revealed 14 hypomethylated and 10 hypermethylated genes in asthma, highlighting potential diagnostic markers and contributing to a better understanding of asthma's pathogenesis for future research and drug development.
View Article and Find Full Text PDF

We aimed to make an integrated analysis of published transcriptome and DNA methylation dataset to ascertain the key differentially methylated and differentially expressed genes for Alzherimer's disease (AD). Two gene expression microarrays and 1 gene methylation microarray were downloaded for identification of differentially expressed genes and differentially methylated genes. Then, we used various biological information databases to annotate the functions of the differentially-methylated/expressed genes, and screen out key genes and important signaling pathways.

View Article and Find Full Text PDF

KDmarkers: A biomarker database for investigating epigenetic methylation and gene expression levels in Kawasaki disease.

Comput Struct Biotechnol J

March 2022

Institute for Translational Research in Biomedicine, Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

Kawasaki disease (KD) is a form of acute systemic vasculitis that primarily affects children and has become the most common cause of acquired heart disease. While the etiopathogenesis of KD remains unknown, the diagnostic criteria of KD have been well established. Nevertheless, the diagnosis of KD is currently based on subjective clinical symptoms, and no molecular biomarker is yet available.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!